Form 4: 10x Genomics CEO Serge Saxonov Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
10x Genomics CEO Serge Saxonov sold 6,749 shares of Class A Common Stock on August 22, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On August 22, 2024, Serge Saxonov, the CEO of 10x Genomics, sold 6,749 shares of Class A Common Stock at a price of $22.5297 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Saxonov directly owns 882,467 shares of Class A Common Stock.
- Additionally, Saxonov indirectly owns shares through several trusts for which he serves as trustee: Andromeda Trust (27 shares), Sirius Trust (870 shares), Y/S Descendants' Trust (213,250 shares), and Y/S Pot Trust (22,570 shares).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Date of stock sale transaction |
| 08/26/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.